Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience-Reference-Cited by-同舟云学术

Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience

Published:2016-07 Issue: Volume:214 Page:419-422
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Maeda Ryozo,Minami Yuichiro,Haruki Shintaro,Kanbayashi Keigo,Itani Ryosuke,Suzuki Atsushi,Ejima Koichiro,Shiga Tsuyoshi,Shoda Morio,Hagiwara Nobuhisa

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

1. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

2. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy;Maron;N Engl J Med,2003

3. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

4. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy;Minami;J Am Coll Cardiol,2011

5. Ventricular tachycardia associated with mid-ventricular obstructive hypertrophic cardiomyopathy and apical aneurysm;Cannava;Int J Cardiol,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy patients with midventricular obstruction;Heliyon;2024-05

2. Magnetic Resonance Left Ventricle Mass-Index/Fibrosis: Long-Term Predictors for Ventricular Arrhythmia in Hypertrophic Cardiomyopathy—A Retrospective Registry;Journal of Cardiovascular Development and Disease;2023-03-13

3. Risk Prediction Models and Scores in Hypertrophic Cardiomyopathy;Current Pharmaceutical Design;2021-04-26

4. Mid‐ventricular obstruction is associated with non‐sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy;Clinical Cardiology;2021-02-24

5. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention;BMC Cardiovascular Disorders;2021-02-19